欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PL/H/0743/004
药品名称
RIXACAM
活性成分
Rivaroxaban 20.0 mg
剂型
Film-coated tablet
上市许可持有人
APC Pharmlog S.A. Al. Jerozolimskie 146C 02-305 Warsaw Poland
参考成员国 - 产品名称
Poland (PL)
RIXACAM
互认成员国 - 产品名称
Germany (DE)
Denmark (DK)
Rixacam
Spain (ES)
Italy (IT)
Latvia (LV)
Slovakia (SK)
许可日期
2022/06/21
最近更新日期
2025/01/29
药物ATC编码
B01AF01 rivaroxaban
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
common 10_mg_pl_IB002G_track
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase